Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-13

Clinical Trial Update: Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how different propranolol dosing frequencies affect sleep in infants with infantile hemangioma; the study was terminated and results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propranolol (propranolol)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Infantile Hemangioma | Phase 4 | Status: TERMINATED | Results posted: 2026-03-13